Anthracyclines and Early Breast Cancer: The End of an Era?

被引：16
作者：
Gianni, Luca [1 ,2 ]
机构：
[1] Ist Tumori Milano, Div Med Oncol, Milan, Italy
[2] Fdn Michelangelo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 08期
关键词：
ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; EPIRUBICIN; DOCETAXEL; METHOTREXATE; PACLITAXEL;
D O I：
10.1200/JCO.2008.20.1640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1155 / 1157
页数：3
相关论文
共 50 条
  • [31] Controversies on chemotherapy for early HR+/HER2-breast cancer: the role of anthracyclines and dose intensification
    Poggio, Francesca
    Molinelli, Chiara
    Giannubilo, Irene
    Lambertini, Matteo
    Blondeaux, Eva
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (06) : 495 - 502
  • [32] Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients
    Wang, Xing
    Wang, Jiwei
    He, Yingjian
    Li, Jinfeng
    Wang, Tianfeng
    Ouyang, Tao
    Fan, Zhaoqing
    CLINICAL BREAST CANCER, 2023, 23 (04) : 423 - 430
  • [33] Combination of taxanes and anthracyclines in first-line chemotherapy of metastatic breast cancer:: an interim report
    Friedrichs, K
    Hölzel, F
    Jänicke, F
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) : 1730 - 1738
  • [34] Chemotherapy for early-stage breast cancer: a brief history
    Verrill, M.
    BRITISH JOURNAL OF CANCER, 2009, 101 : S2 - S5
  • [35] A population-based study on the patterns of use of different chemotherapy regimens in patients with early breast cancer
    Joerger, Markus
    Ess, Silvia
    Dehler, Silvia
    Savidan, Anita
    Bouchardy, Christine
    Frick, Harald
    Konzelmann, Isabelle
    Thuerlimann, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [36] Trastuzumab and Emerging Targeted Therapies for HER2-Amplified Early-Stage Breast Cancer
    Gajria, Devika
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 28 - 35
  • [37] The role of liposomal anthracyclines in metastatic breast cancer
    Gennari A.
    Piccininno M.
    Sarti S.
    Current Breast Cancer Reports, 2013, 5 (1) : 23 - 30
  • [38] Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer-8-year results of the Breast International Group 02-98 phase III trial
    Oakman, C.
    Francis, P. A.
    Crown, J.
    Quinaux, E.
    Buyse, M.
    De Azambuja, E.
    Margeli Vila, M.
    Andersson, M.
    Nordenskjold, B.
    Jakesz, R.
    Thuerlimann, B.
    Gutierrez, J.
    Harvey, V.
    Punzalan, L.
    Dell'Orto, P.
    Larsimont, D.
    Steinberg, I.
    Gelber, R. D.
    Piccart-Gebhart, M.
    Viale, G.
    Di Leo, A.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1203 - 1211
  • [39] Early Breast Cancer in the Older Woman
    Gandhi, Sonal
    Verma, Sunil
    ONCOLOGIST, 2011, 16 (04) : 479 - 485
  • [40] Adjuvant treatment for early breast cancer
    Smith, I
    ANNALS OF ONCOLOGY, 2005, 16 : 182 - 187
12345